NEW PALTZ, N.Y., May 4 /PRNewswire-FirstCall/ -- American Scientific Resources (PNK: ASFX) today announced the launch of its flagship Heart Smart System(TM), a unique line of nutraceutical products that assist in the successful prevention of cardiovascular disease. Heart Smart System(TM) is a nutritional line of supplements which support and maintain a healthy heart. American Scientific has formed an exclusive partnership with Tishcon Corp., a privately held contract manufacturer of nutritional supplements based in Westbury, NY, to produce the patented Heart Smart brand. Tishcon is licensed by the Food and Drug Administration (FDA). Heart Smart contains a proprietary blend that includes a 100% soluble supplement for Coenzyme Q10 (CoQ10), which is found in every cell of the body and is critical in the production of energy, and maintenance of healthy heart function. Through Heart Smart, the supply of CoQ10 is rejuvenated and yields numerous beneficial effects, including an overall healthier immune system. The goal is to help combat cardiovascular disease, which is attributed to approximately 1 million deaths or injuries per year in the U.S. and implicated in an additional 9 million deaths per year nationwide. Walter Lambert, Chairman and Chief Executive Officer of American Scientific stated, "The launch of our revolutionary flagship product represents a major milestone for our company. We are excited to partner with Tishcon to create our patented, clinically proven nutritional supplement that provides a safe and effective alternative for promoting heart health. By focusing on the prevention of cardiovascular disease, we believe our Heart Smart System(TM) can relieve one of the leading causes of premature and avoidable deaths among adult Americans without incurring dramatic changes to a person's lifestyle." Mr. Lambert added, "Heart Smart is paramount in the execution of our growth strategy. We are excited by Heart Smart's vast potential in the multi-billion dollar nutritional supplement market and look forward to educating consumers and building brand awareness as we roll out our products. We expect to expand the distribution of our Heart Smart System(TM) through a comprehensive direct marketing campaign as well as mass market retailers such as drug stores, grocery stores, mass merchandisers, and more." George McShane, Director of Sales and Marketing at Tishcon, said, "We are pleased to team with American Scientific. Our 30-year history in production of technologically advanced nutritional supplements combined with American Scientific's strong distribution platform provides a significant growth opportunity. We believe our patented nanotechnology, Biosolve(TM), for the 100% dissolution of CoQ10 throughout the body presents a distinct advantage over other products in the market. Our initial plan is to offer Heart Smart via capsule tablet or chewable form and strengthen the human cardiovascular system for people throughout the U.S." About American Scientific Resources American Scientific Resources, Inc. is an emerging holding company based in upstate New York that provides a broad range of healthcare and medical products distributed primarily by surgical supply dealers and retail drug chains. The company is comprised of three core operating subsidiaries: 1) Heart Smart System, Inc., the company's flagship product offering focused on the successful prevention of cardiovascular disease using its patented CoQ10 supplement 2) Kidz-Med, Inc., a leading brand of safe and innovative pediatric products, and 3) Ulster Scientific, Inc., a manufacturer and distributor of unique medical products and laboratory diagnostic equipment founded in 1974. American Scientific Resources' growing, national customer base includes Walgreens, CVS, Cardinal Health and Fisher Scientific. SAFE HARBOR STATEMENT: This news release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward- looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements, including the risks that our products may not achieve customer acceptance or that they will not perform as expected, that customer trials will not lead to future sales, and other risks identified in our annual report on Form 10-K and other filings with the SEC. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements are made as of the date hereof and DVS undertakes no obligation to update such statements.
SOURCE American Scientific Resources